UNSPSC 41202063: Streptococcus spp. serological reagents

In this classification, Streptococcus genus serological reagents are devices used in test to identify specific Streptococcus genus antibodies in serum. US FDA regulates Streptococcus genus serological reagents under 21 CFR 866.3740 and under FDA product code GTY.

UNSPSC 41202063 Streptococcus spp. serological reagents (Commodity) covers rapid diagnostic test kits, reagents, and related supplies for infectious disease screening and confirmation testing across state and local public health, correctional, and clinical laboratory settings. State and local governments procure these supplies primarily for sexually transmitted infection (STI) testing, HIV screening, and syphilis detection through public health departments, county corrections agencies, county health services, and municipal public health programs. Recent opportunities show demand for bundled reagent systems compatible with specific analyzer platforms (Abbott ARCHITECT, Hologic Panther), along with control kits, calibrators, and in some cases analyzer maintenance contracts as part of broader laboratory service agreements.

Illinois Department of Public Health, Collin County (Texas), Gwinnett County (Georgia), and the City of Austin represent recent issuing bodies. The Illinois Department of Public Health has issued multiple procurements for Abbott HIV/Syphilis reagents and Hologic NG/NT testing kits—including an emergency sole-source purchase in May 2026 ($38,079.50 to Abbott Laboratories) and a change order in September 2026 increasing annual NG/CT test volumes from 15,000 to 25,000 tests and collection kits from 15,000 to 30,000 units, raising the total contract cost to $900,000 over five years. Collin County issued an RFP in September 2026 for offender specimen collection and drug testing services (approximately 25,031 annual tests, $600,000 estimated value), while the City of Austin released competing IFBs in June and August 2026 for rapid HIV test kits (Abbott Determine HIV 1/2 Ag/Ab Combo, approximately 375 kits annually). Gwinnett County posted an RFP in September 2026 for drug testing supplies compatible with an existing drugs of abuse analyzer, though limited scope details appear in the notice. Recent activity concentrates in Illinois, Texas, and Georgia; the code shows active procurement momentum in state public health laboratories and county correctional health operations through competitive IFBs and RFPs, as well as emergency sole-source awards when supply chain continuity for proprietary analyzer systems is at risk.